Chai Discovery, a San Francisco-based biotech startup founded in 2024, develops AI foundation models like Chai‑1 and Chai‑2 for molecular design. Backed by OpenAI and top VCs, it accelerates drug discovery, enabling faster, cost-effective breakthroughs for pharma and biotech companies.
